...

首页> 外文期刊>European Journal of Cancer Supplements >801 Oral chemotherapy and upper gastro-intestinal tolerance (UGT) improvement of nausea and vomiting in non-small-cell-lung-cancer (NSCLC) patients (pts) treated with oral navelbine (NVB) and standard antiemetic prophylaxis

【24h】

801 Oral chemotherapy and upper gastro-intestinal tolerance (UGT) improvement of nausea and vomiting in non-small-cell-lung-cancer (NSCLC) patients (pts) treated with oral navelbine (NVB) and standard antiemetic prophylaxis

机译：801口服萘韦尔滨（NVB）和标准止吐药治疗的非小细胞肺癌（NSCLC）患者（pts）的口服化疗和上消化道耐受性（UGT）改善的恶心和呕吐

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2003年第5期|共2页
作者
C.Gridelli; Y.Parlier; M.Brandely; D.Aubert; L.Nguyen; J.Jassem;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 801 Oral chemotherapy and upper gastro-intestinal tolerance (UGT) improvement of nausea and vomiting in non-small-cell-lung-cancer (NSCLC) patients (pts) treated with oral navelbine (NVB) and standard antiemetic prophylaxis [J] . C.Gridelli, Y.Parlier, M.Brandely, European Journal of Cancer Supplements . 2003,第5期

机译：801口服萘韦尔滨（NVB）和标准止吐药治疗的非小细胞肺癌（NSCLC）患者（pts）的口服化疗和上消化道耐受性（UGT）改善的恶心和呕吐
2. Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States [J] . SchwartzbergL., MorrowG., BaluS., Current medical research and opinion . 2011,第8期

机译：在美国医院门诊患者中，用帕洛诺司琼与其他5-HT3受体拮抗剂进行化学疗法诱导的恶心，呕吐和止吐预防
3. 815 Elderly patients (pts) with unresectable localised or metastatic non-small-cell-lung-cancer (NSCLC): results of a phase II study with oral navelbinea? (nvb) given as a weekly monotherapy and first line treatment [J] . U.Gatzemeier, F.De Marinis, C.Manegold, European Journal of Cancer Supplements . 2003,第5期

机译：815患有不可切除的局限性或转移性非小细胞肺癌（NSCLC）的老年患者（pts）：一项针对口服肚脐菌的II期研究的结果？（nvb）每周一次单一疗法和一线治疗
4. A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting [O] . M. Clemons, G. Dranitsaris, M. Sienkiewicz, 2020

机译：化疗诱导的乳腺癌患者的个性化与护理抑制疗法的随机试验高风险化疗诱导的恶心和呕吐
5. Chemotherapy is one of the therapies for cancer patients that cause some side effects, one of them is nausea and vomiting. Nausea and vomiting are still felt by patients even though they take antiemetics. Nausea dan vomiting can cause fluid and electrolyte imbalance. The aim of this study was to analysis the effect of combination acupressure wristband and antiemetic among chemotherapy induced nausea vomiting (CINV) on breast cancer patients. This research used quasi experimental research method, with a pre-post test with the control group. The sampling techniques was consecutive sampling with 25 respondents both in intervention group and control group. In the intervention group had received an acupressure wristband. CINV measured on the second day until fourth day after chemotherapy. Nausea and vomiting score were measured twice a day by a telemonitoring methode by Rhodes Index Nausea, Vomiting and Retching (INVR) questionaire. Data were analyzed by paired t-test, independent t-test, Wilcoxon test and Mann Whitney. The result of this study showed that acupressure wristband significantly reduce the chemotherapy induced nausea and vomit (p value = 0.000). The use of acupressure wristband combined with antiemetic therapy can significantly decrease chemotherapy induced nausea and vomiting in breast cancer patients. Acupressure wristband recommended for consideration nursing intervention in treating breast cancer patients who experience nausea and vomiting. [O] . Endah Fatma 2018

机译：化疗是癌症患者的疗法之一，导致一些副作用，其中一个是恶心和呕吐。患者仍然感受到恶心和呕吐，即使他们服用助性学。恶心丹呕吐会导致液体和电解质不平衡。本研究的目的是分析组合组合腕带和抑制在乳腺癌患者中的诱导恶心呕吐（CINV）的影响。本研究使用了准实验研究方法，用对照组进行了预先测试。采样技术是在干预组和对照组中进行25名受访者的连续抽样。在干预组中，收到了一名腕带。 Cinv在化疗后第四天测量。通过罗得岛指数恶心，呕吐和转换（INVR）问卷，每天测量恶心和呕吐分数。通过配对的T检验，独立的T检验，Wilcoxon测试和Mann Whitney分析数据。该研究的结果表明，Acuruce腕带显着降低化疗诱导的恶心和呕吐物（P值= 0.000）。使用Acu压抑腕带与止吐疗法相结合，可以显着降低乳腺癌患者诱导的恶心和呕吐。 Acu压痕腕带推荐用于治疗体验恶心和呕吐的乳腺癌患者的护理干预。

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号